🔎 Trials Near Me

Akèy › Ipètansyon pulmonè › Oregon

Etid klinik pou Ipètansyon pulmonè nan Oregon

10 etid pou Ipètansyon pulmonè ap chèche patisipan nan sit nan Oregon.

Vil nan Oregon

Tèks ofisyèl etid la (Anglè)

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

  • Clinical Research Site, Bend
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 11, 2026 · NCT07816185

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • Summit Health, Bend
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Summit Health, Bend
  • Legacy Research Institute, Portland
  • Oregon Health & Science University, Portland
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

  • Randall Children's Hospital-Portland (RCH), Portland
Ap rekriteFaz 4
0 Months – 1 Month · Tout sèks · Mizajou Aug 18, 2026 · NCT05213676

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

  • Summit Health, Bend
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Jun 26, 2026 · NCT06129240

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • Oregon Health & Science University, Portland
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195

Pulmonary Hypertension Association Registry

  • The Oregon Clinic, Portland
Ap rekriteEtid obsèvasyon
Laj 0 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT04071327

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.